Production Scanners

PRODUCTS

  • Learn how our 4,000-square-foot cGMP manufacturing site is purpose-built to support your microbial program from pre-clinical to commercial manufacturing.

  • With our Switch 350, you benefit from the advantages of two machine concepts: We have combined the modularity, handling options, and technologies of our well-proven standard platforms with the flexibility of our small batch inspection machine to run syringes and vials on one and the same machine – with nesting system for syringes and vials alike.

  • FILTRASORB® granular activated carbon (GAC) represents Calgon Carbon’s signature product line, providing over 60 years of successful contaminant removal. Developed for the removal of organic compounds from water, Calgon Carbon’s best-in-class FILTRASORB products have the trifecta of key activated carbon attributes: high overall performance, strength/durability, and competitive pricing. Acting as a dual-purpose media, FILTRASORB provides both filtration and adsorption for treating surface water and groundwater in the production of clean, safe drinking water.

  • Setting a New Benchmark for Ease of Operation

    The NP-255 is a robust tablet press that was built to meet even the most demanding needs of the mid-sized tableting industry. The press has features and options designed to increase production, improve tablet quality, reduce waste, and set a new benchmark for ease of operation. Designed, engineered, and manufactured in the USA, this unique machine has a maximum production speed of 192,000 tablets per hour.

    With a hardened steel die table, a gravity feeder that is interchangeable with a two-paddle forced feeder, and our industry-leading intuitive Natoli AIM™ ProPluscontrol system, the NP-255 is the new standard for value in the mid-sized tableting industry.

  • Curia’s combined expertise and a proven track record of success in key scientific disciplines including molecular biology, protein production and analysis, enzymes, nucleosides and lipids is the foundation of our mRNA solution. Partner with us and harness our ability to provide high-quality constructs through in-house research and analysis capabilities that enable accelerated timelines for delivery.

WHITE PAPERS AND CASE STUDIES

NEWS